83 of the 163 Southeast Asian companies listing overseas between 2014 and 2023 chose HKEX, compared with 41 choosing other Asia-Pacific exchanges, 23 listing on American exchanges and 10 floating on European exchanges.
The US$3.2bn raised by Southeast Asian companies with HKEX between 2014 and 2023 compares with the US$1.9bn raised on other major global exchanges between 2014 and 2023. The pipeline for future listings looks strong too, with DealStreetAsia research finding that more than 200 startups in the region reached late-stage status in 2023. These late-stage companies may come to the public markets in the near future.
Consumer, technology, healthcare and new energy sectors are popular industries seeking fundraising in Hong Kong. Companies in the consumer sector alone have raised more than US$100bn through IPOs. Since HKEX’s 2018 listing reforms, over 250 Tech issuers have raised over US$50bn, while companies in the healthcare sector have raised more than US$36bn. HKEX is also home to over 75 new energy companies from across the EV value chain, with car, battery and mineral companies listed on our market.
HKEX Adds Indonesia Stock Exchange as Recognised Stock Exchange
HKEX Signs Cooperation Agreement with Indonesia Stock Exchange
List of Recognised Stock Exchanges
HKEX’s Stock Connect programme stands out as the only channel available for global issuers to access capital from Mainland China. Through Southbound Stock Connect, HKEX offers a unique opportunity for IPO hopefuls to tap both international and Mainland Chinese capital.
The report explores the fundraising landscape in Southeast Asia, Exit / IPO considerations, and highlights HKEX’s unique role in connecting innovative new economy companies from Southeast Asia with international and Mainland Chinese capital. It also discusses why HKEX is particularly well suited as listing venue of choice for Southeast Asian companies, and contains valuable market data and information on our ongoing listing regime enhancements.
HKEX continuously looks for ways to enhance our listing regimes to support the liquidity, vibrancy and attractiveness of our marketplace.
Launch of New Economy Listing Reforms (Chapter 8A, 18A and 19C) introducing new rules for weighted voting rights, pre-revenue biotech companies, and secondary listings
Inclusion of weighted voting rights (WVR) listed companies in Southbound Stock Connect
HKEX-listed biotech companies added to Southbound Stock Connect
Enhanced Listing Regime for Overseas Issuers & Launch of SPAC Listing Regime (Chapter 18B)
Launch of IR Connect
Inclusion of ETFs in Stock Connect
Launch of 18C Specialist Technology listing regime
Launch of FINI
Introduction of a new transfer mechanism and test requirements to eligible Growth and Enterprise Market (GEM) issuers.
De-SPAC and Specialist Technology listing requirements temporarily modified
我们为发行人提供多种前来香港上市的途径，为发行人上市之旅的每一步提供帮助。
主板：
GEM: